The stock of DarioHealth Corp (NASDAQ:DRIO) hit a new 52-week low and has $2.49 target or 12.00% below today’s $2.83 share price. The 8 months bearish chart indicates high risk for the $13.90M company. The 1-year low was reported on Nov, 2 by Barchart.com. If the $2.49 price target is reached, the company will be worth $1.67 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 21,413 shares traded hands. DarioHealth Corp (NASDAQ:DRIO) has declined 35.96% since March 31, 2016 and is downtrending. It has underperformed by 38.49% the S&P500.
Analysts await DarioHealth Corp (NASDAQ:DRIO) to report earnings on November, 11. They expect $-0.37 earnings per share, up 58.89% or $0.53 from last year’s $-0.9 per share. After $-0.49 actual earnings per share reported by DarioHealth Corp for the previous quarter, Wall Street now forecasts -24.49% EPS growth.
According to Zacks Investment Research, “DarioHealth Corp. creates mobile and digital tools. The company’s product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors and healthcare systems. DarioHealth Corp., formerly known as LabStyle Innovations Corp., is based in Ramat Gan, Israel.”
More notable recent DarioHealth Corp (NASDAQ:DRIO) news were published by: Prnewswire.com which released: “DarioHealth Reports Successful Traction for Dario” on October 25, 2016, also Prnewswire.com with their article: “DarioHealth Preps for New iPhone” published on September 08, 2016, Prnewswire.com published: “DarioHealth Launches New Digital Platform and Online Store in Canada” on September 27, 2016. More interesting news about DarioHealth Corp (NASDAQ:DRIO) were released by: Prnewswire.com and their article: “DarioHealth Reports Second Quarter 2016 Results” published on August 11, 2016 as well as Prnewswire.com‘s news article titled: “LabStyle Innovations Now DarioHealth” with publication date: July 27, 2016.
DRIO Company Profile
DarioHealth Corp, formerly Labstyle Innovations Corp, incorporated on August 11, 2011, is a digital health (mHealth) company. The Firm is engaged in developing and commercializing a technology providing clients with laboratory-testing capabilities using smart phones and other mobile devices. The Company’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.